isosorbide-5-mononitrate has been researched along with Angor Pectoris in 183 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 70 (38.25) | 18.7374 |
| 1990's | 77 (42.08) | 18.2507 |
| 2000's | 32 (17.49) | 29.6817 |
| 2010's | 4 (2.19) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gillion, AR; Kessler, SG; Pattanaik, D; Rogers, KC | 1 |
| Ge, L; Gong, Y; Jiang, L; Liu, J; Liu, Q; Shi, Y; Zheng, C; Zhu, J | 1 |
| Fujimura, N; Hidaka, T; Higashi, Y; Kajikawa, M; Kihara, Y; Liao, JK; Maruhashi, T; Matsumoto, T; Nakashima, A; Noma, K | 1 |
| Kozlova, NV; Shameeva, ES; Sizova, ZM; Zakharova, VL | 1 |
| Berezina, AV; Demchenko, EA; Panov, AV | 1 |
| Schneider, CA | 1 |
| André-Fouet, X; Francillon, A; Le Gal, M; Marquis, P | 1 |
| Belenkov, IuN; Bishele, NA; Chazova, IE; Demura, SA; Dmitriev, VV; Lebedeva, NA; Pavlov, VE; Ratova, LG | 1 |
| George, J; Golovner, M; Kitzis, I; Laniado, S; Roth, A; Shapira, I; Zandorf, D | 1 |
| Kardas, P | 1 |
| Martsevich, SIu | 1 |
| Chirkov, YY; Holmes, AS; Horowitz, JD; Pereira, J; Poropat, S; Willoughby, SR | 1 |
| Ageev, FT; Belenkov, IuN; Dzhakhangirov, TSh; Nuraliev, EIu; Prostakova, TS | 1 |
| Aksenova, EA; Demin, AA | 1 |
| Balakhonova, TV; Kazachkina, SS; Lupanov, VP; Naumov, VG; Pogorelova, OA; Rogoza, AN | 1 |
| Logvinenko, SI; Shcherban', EA; Zaslavskaia, RM | 1 |
| Alimova, EV; Dmitrieva, nA; Egorov, VA; Koniakhina, IP; Kozyreva, MP; Lukina, IuV; Martsevich, SIu; Semenova, IuE | 1 |
| Daida, H; Kawakubo, K; Kusama, Y; Nakazato, K; Satoh, H; Shimada, K; Sunayama, S | 1 |
| Shilov, AM | 1 |
| Chen, JZ; Guo, JX; He, Q; Jia, SQ; Li, TD; Li, ZQ; Shan, YD; Wei, JP; Wu, ZG; Yang, XC; You, K; Zhu, WL | 1 |
| Logvinenko, SI; Shcherbakov, EA; Zaslavskaia, RM | 1 |
| Glocke, M; Müller, G; Uberbacher, HJ | 1 |
| Haase, W; van Hasselt, P; Weiss, M | 1 |
| Blasini, R; Brügmann, U; Reiniger, G; Rudolph, W | 1 |
| Abshagen, U; Glocke, M; Uberbacher, HJ | 1 |
| Häcker, W; Müller, G; Schneider, B | 1 |
| Bussmann, WD | 1 |
| Kayali, A | 1 |
| Silber, S | 2 |
| Jansen, W; Metternich, M; Osterspey, A; Tauchert, M | 1 |
| Haase, W; van Hasselt, M; Weiss, M | 1 |
| Haase, W; Marten, W; Weiss, M | 1 |
| Jobst, E; Keller, H; Schmidt, G | 1 |
| Rietbrock, N; Woodcock, BG | 1 |
| Schaumann, W | 1 |
| Bussmann, WD; Kaltenbach, M; Reifart, F; Reifart, N | 1 |
| Andresen, D; Arntz, R; Biamino, G; Lichey, HJ; Oeff, M; Prokein, E; Schröder, R; von Leitner, E | 1 |
| Botvin, S; Caspi, A; Marmor, A; Reizin, L; Schneeweiss, A | 1 |
| Agabiti-Rosei, E; Motolese, M; Savonitto, S | 1 |
| Held, P; Olsson, G | 1 |
| Bueno, O; Zavecz, JH | 1 |
| Lipicky, RJ; Thadani, U | 1 |
| Bogaert, MG | 1 |
| Ahlner, J; Torfgård, KE | 1 |
| de Vries, RJ; Dunselman, PH; Lie, KI; van den Heuvel, AF; van Veldhuisen, DJ; Wielenga, RP | 1 |
| Blagodatskikh, SV; Kozyreva, MP; Kutishenko, NP; Martsevich, SIu; Metelitsa, VI; Simkhaev, LS; Slastnikova, ID; Vakulovskaia, MK | 1 |
| Bassan, M | 1 |
| Klein, HO | 1 |
| Caspi, A; Marmor, A; Reisin, L; Schneeweiss, A | 1 |
| Amsterdam, E; Chernoff, R; Friedman, RG; Gorwit, J; Hinderaker, PH; Maranda, CR; Spaccavento, L; Thadani, U; Zellner, S | 1 |
| Kiser, WR; Poss, M; Racicot, D | 1 |
| Thadani, U | 2 |
| Nordlander, R; Walter, M | 1 |
| Parker, JO | 4 |
| Bittar, N; Casareto, R; Chrysant, SG; Danisa, K; Ferraresi, R; Garutti, RJ; Glasser, SP; Ibrahim, R; Shahidi, FE; Watts, LE | 1 |
| Amado, JA; Berrazueta, JR; Ochoteco, A; Poveda, JJ; Riestra, A; Salas, E | 1 |
| Bailey, AE; Curry, PV; Steare, SE; Walker, JM | 1 |
| Cleophas, TJ; Niemeyer, MC; van der Meulen, J; van der Wall, EE | 1 |
| Baxter, T; Eadie, CJ | 1 |
| Cleophas, TJ; Niemeyer, MG | 1 |
| Anchipolovskaia, NG; Bart, BIa; Dergunova, EN; Kulikov, SI; Mamtsev, BN; Mikhaĭlusova, MP; Smirnova, OL | 1 |
| Nyberg, G | 2 |
| Chernov, SA; Gospodarenko, AL; Kutepov, IuS; Malenik, OM; Tiurin, VP; Virs, EA | 1 |
| Berman, DS; Lewin, HC | 1 |
| Brown, RE; Halpern, MT; Kendall, MJ | 1 |
| Cleophas, TJ; de Ree, R; Kleinjans, HA; Niemeyer, MG; van der Wall, EE; Zwinderman, AH | 1 |
| Belousov, IuB; Egorova, NA; Karasev, AV; Upnitskiĭ, AA | 1 |
| Glasser, SP | 1 |
| Parker, JD; Parker, JO | 1 |
| Hjalmarson, A; Johansson, M; Lomsky, M; Lurje, L; Vahisalo, R; Wennerblom, B; Westberg, S | 1 |
| Zaslavskaia, RM; Zhamankulov, KA; Zholdin, BK | 1 |
| Avery, PG; Hall, RJ; Jones, E; Linka, AZ; Masani, ND; Rinaldi, CA; Saunders, H | 1 |
| Chen, YH; Ding, PY; Wang, SP | 1 |
| Markham, A; Prakash, A | 1 |
| Gunasekara, NS; Noble, S | 1 |
| Waller, DG | 1 |
| Buunk, BP; Cleophas, TJ; Niemeyer, MG; van der Sluijs, H; van der Wall, EE; Zwinderman, AH | 1 |
| Courteney-Harris, R; Hider, JD; Shehab, Z | 1 |
| Adhikari, P; Bhat, P; Kumar, PU; Pereira, P | 1 |
| Dinsmore, WW; Levi, R; Muirhead, GJ; Sutton, JA; Webb, DJ; Wulff, M | 1 |
| Cleophas, TJ; Niemeyer, MG; van der Wall, EE; Zwinderman, AH | 1 |
| Alekseeva, IA; Chotchaev, KhKh; Lupanov, VP; Naumov, VG; Vasil'eva, NN | 1 |
| Cleophas, TJ; Jansen, R; Niemeyer, MG; Zwinderman, AH | 2 |
| Hayashi, T; Ishikawa, K; Kanamasa, K; Kimura, A; Kitayama, K; Miyataka, M; Takenaka, T; Yabushita, H; Yamamoto, T | 1 |
| Afanas'eva, IuV; Alekseeva, IA; Lupanov, VP; Naumov, VG; Romasiuk, SS; Vasil'eva, NN | 1 |
| Karlsson, T; Lurje, L; Tygesen, H; Vahisalo, R; Wennerblom, B | 1 |
| Czapla, J; Hamankiewicz, M; Kucio, C; Wójcik, P | 1 |
| Dolovich, LR; Grootendorst, PV; Holbrook, AM; Levy, AR; O'Brien, BJ | 1 |
| Chong, C; Hall, R | 1 |
| Keck, M; Sauerbrey-Wullkopf, N; Tretter, R | 1 |
| Aleshin, OI; Barysheva, OV; Bezborodova, IuV; Chernova, EV; Kuchinskaia, NG; Shatukhina, EIu | 1 |
| Wagner, G | 1 |
| Carboni, GP; Prati, PL; Risa, AL; Saltarocchi, ML; Scardovi, AB; Zanchi, E | 1 |
| de Vane, PJ; Thadani, U | 1 |
| Ganzinger, U | 1 |
| Allgén, J; Amtorp, O; Nyberg, G; Olsson, G; Parker, JO | 1 |
| Bittar, N; Thadani, U | 1 |
| Akhras, F; Jackson, G | 1 |
| Akhras, F; Eteiba, H; Foale, RA; Hallam, RJ; Hutton, I; Jackson, G; Prescott, RJ; Quinn, KJ | 1 |
| Bulitta, M; Hilbich, K; Krepp, P; Neuhaus, R; Patyna, WD; Puespoek, J; Rittinghausen, R; Ueberbacher, HJ | 1 |
| Krepp, HP | 1 |
| Brunner, D; Meshulam, N; Waysbort, J | 1 |
| Koch, JE; Ontanilla, E; Yasky, J | 1 |
| Beck, EJ; Koch, JE | 1 |
| Ahmadinejad, M; Eghbal, B; Ensslin, HD; May, K; Weiss, M | 1 |
| Keck, M | 1 |
| Jansen, W; Kümper, H; Laufen, H; Prenzel, R; Rappert, B; Tauchert, M | 1 |
| Cadeddu, M; Cherchi, A; Lai, C; Lai, G; Onnis, E; Orani, E; Solinas, R | 1 |
| Andresen, D; Brüggemann, T; Hennig, A; Hennig, L; Levenson, B; Schröder, R | 1 |
| Anggård, E; Arvill, A; Jörgensen, E | 1 |
| Avila Escribano, C; Cascón Bueno, M; Diego Domínguez, M; Fernández Esteban, T; Martín Luengo, C; Nieto Ballesteros, F; Pavón Osuna, P; Santos Rodríguez, I | 1 |
| Jonsson, UE | 1 |
| Adao, M; Aleixo, AM; Bruges, G; Machado, FP; Mendes, M; Palos, JL; Seabra-Gomes, R | 1 |
| Feng, JZ; Feng, XH; Schneeweiss, A | 1 |
| Kendall, MJ | 1 |
| Blagodatskikh, SV; Egorov, LV; Martsevich, SIu; Metelitsa, VI; Simkhaev, LS; Slastnikova, ID | 1 |
| Jansen, W; Kümper, H; Prenze, R; Tauchert, M | 1 |
| Adam, WE; Grossmann, G; Stauch, M; Wanjura, D | 1 |
| Wrobel, N | 1 |
| Aldershvile, J; Klarlund, K; Svendsen, JH; Waldorff, S | 1 |
| Abildgaard, U; Aldershvile, J; Amtorp, O; Svendsen, JH | 1 |
| DasGupta, P; Hughes, LO; Jain, D; Lahiri, A; Raftery, EB | 1 |
| Bayeric, A; Dirschinger, J; Hall, D; Reiniger, G; Rudolph, W | 1 |
| Akhras, F; Chambers, J; Jackson, G; Jefferies, S | 1 |
| Ake, H; Arina, R; Emanuelsson, H; Kristi, M | 1 |
| Jansen, W; Kümper, H; Prenzel, R; Tauchert, M; Weidmann, B | 1 |
| Caporale, R; Lagioia, R; Loliva, F; Mancini, G; Mangini, SG; Mastropasqua, F; Rizzon, P; Scrutinio, D | 1 |
| Beyerle, A; Dirschinger, J; Reiniger, G; Rudolph, W | 1 |
| Barillà, F; Ciolli, A; Ferraironi, A; Pannarale, G; Pelliccia, F; Romeo, F; Valente, A; Vicchio, D | 1 |
| Goddard, MD; Nichol, P; Roks, C; Wisenberg, G | 1 |
| Uusitalo, A | 1 |
| Aberg, A; Engvall, J; Härkönen, R; Keyriläinen, O; Nyberg, G; Olsson, G; Rehnqvist, N; Rosenqvist, U; Ulvenstam, G; Uusitalo, A | 1 |
| Amtorp, O; Svendsen, JH | 1 |
| Aberg, A; Engvall, J; Härkönen, R; Keyriläinen, O; Nyberg, G; Rautio, P; Rehnqvist, N; Rosenqvist, U; Ulvenstam, G; Uusitalo, A | 1 |
| Cherchi, A; Lai, C; Onnis, E; Orani, E; Pirisi, R; Soro, A | 1 |
| Johnen, R; Neuhaus, R; Solbach, C; Vydra, L | 1 |
| Gathmann-Lewik, U; Heepe, W | 1 |
| Thadani, U; Whitsett, T | 1 |
| Ahmadinejad, M; Eghbal, B; Schneeweiss, A; Sorgenicht, W; Weiss, M | 1 |
| Beyerle, A; Dirschinger, J; Hall, D; Reiniger, G; Rudolph, W | 1 |
| Aberg, A; Engvall, J; Keyriläinen, O; Nyberg, G; Olsson, G; Rehnqvist, N; Reinikainen, P; Rosenqvist, U; Ulvenstam, G; Uusitalo, A | 1 |
| Alaimo, G; Centineo, G; Licata, G; Nardi, E; Novo, S; Strano, A | 1 |
| von Arnim, T | 1 |
| Crake, T; Fox, KM; Mockus, LJ; Quyyumi, AA; Wright, CM | 1 |
| Bidoggia, H | 1 |
| Bonn, R | 1 |
| Erath, A; Reuschel-Janetschek, E; von Arnim, T | 1 |
| Herrmann, H; Kuhl, A; Maier-Lenz, H | 1 |
| Geppert, R; Jansen, W; Tauchert, M; Weidmann, B | 1 |
| Amico, C; Bosimini, E; Schiavoni, G | 1 |
| Fazzini, PF; Pucci, P | 1 |
| Aberg, A; Aström, H; Carlens, P; Lindström, E; Lundman, T; Nordlander, R; Nyberg, G; Rehnqvist, N; Ulvenstam, G | 2 |
| Bleifeld, W; Erlemeier, HH; Kupper, W; Lange, S | 1 |
| Distante, A; L'Abbate, A; Lombardi, M; Morales, MA; Moscarelli, E | 1 |
| Kenedi, P | 1 |
| Cannizzaro, S; Davì, G; Giubilato, A; Mattina, A; Novo, S; Strano, A | 1 |
| Doyle, R; Hamilton, SF; Karpow, SA; Prasad, R; Reder, R; Teague, SM; Thadani, U; Voyles, WF | 1 |
| Meffert, M; Paeckelmann, IM | 1 |
| Doyle, R; Hamilton, SF; Karpow, S; Prasad, R; Reder, R; Teague, SM; Thadani, U; Voyles, W | 1 |
| Brunner, D; Meshulam, N; Weisbort, J | 1 |
| Kamihara, S; Kitamura, J; Koide, M; Miyahara, T; Noda, S; Sotobata, I; Tsunekawa, A; Tsuzuki, M; Yokota, M | 1 |
| Kardash, MM; Kohli, RS; Raftery, EB; Rodrigues, EA; Whittington, JR | 1 |
| Anderson, JL; Doyle, R; Hamilton, SF; Kirsten, E; Olson, E; Prasad, R; Teague, SM; Thadani, U; Voyles, W | 1 |
| Cherchi, A; Lai, C; Meloni, L; Onnis, E; Pirisi, R | 1 |
| Grosswendt, J; Klütsch, K; Koch, E; Schöniger, F | 1 |
| Gleichmann, U; Kabelitz, K; Mannebach, H; Mertens, HM; Ohlmeier, H | 1 |
| Brodie, NH; O'Hara, H; O'Hara, J; Valle-Jones, JC | 1 |
| Akhras, F; Jackson, G; Jefferies, S | 1 |
| Accettura, D; Antuofermo, F; De Nicolò, M; De Toma, L; Lagioia, R; Mangini, SG; Preziusi, N; Rizzon, P; Saliani, P; Scrutinio, D | 1 |
| Abildgaard, U; Aldershvile, J | 1 |
24 review(s) available for isosorbide-5-mononitrate and Angor Pectoris
| Article | Year |
|---|---|
[Nitrates. The place in contemporary therapy of ischemic heart disease].
Topics: Angina Pectoris; Contraindications; Delayed-Action Preparations; Humans; Isosorbide Dinitrate; Myocardial Infarction; Myocardial Ischemia; Nitrates; Nitroglycerin; Time Factors; Vasodilator Agents | 2005 |
[Nitrates in the practice of treatment of cardiovascular diseases].
Topics: Angina Pectoris; Cardiovascular Diseases; Humans; Isosorbide Dinitrate; Nitrates; Vasodilator Agents | 2006 |
[Acute and long-term nitrate treatment of angina pectoris].
Topics: Acute Disease; Administration, Oral; Angina Pectoris; Bandages; Drug Tolerance; Humans; Infusions, Parenteral; Isosorbide Dinitrate; Long-Term Care; Mouth Floor; Nitroglycerin; Ointments | 1983 |
Pharmacologic therapy of angina pectoris.
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Aspirin; Calcium Channel Blockers; Drug Therapy, Combination; Enoximone; Heparin; Humans; Isosorbide Dinitrate; Niacinamide; Nicorandil; Nitroglycerin; Piperazines; Ranolazine; Vasodilator Agents | 1995 |
Short and long-acting oral nitrates for stable angina pectoris.
Topics: Administration, Oral; Angina Pectoris; Delayed-Action Preparations; Drug Therapy, Combination; Drug Tolerance; Humans; Isosorbide Dinitrate; Nitrates; Nitroglycerin; United States; United States Food and Drug Administration; Vasodilator Agents | 1994 |
Clinical pharmacokinetics of nitrates.
Topics: Angina Pectoris; Delayed-Action Preparations; Drug Administration Routes; Half-Life; Humans; Isosorbide Dinitrate; Liver; Nitrates; Nitroglycerin; Structure-Activity Relationship; Vasodilation; Vasodilator Agents | 1994 |
Mechanisms of action of nitrates.
Topics: Angina Pectoris; Blood Platelets; Cyclic GMP-Dependent Protein Kinases; Cytochrome P-450 Enzyme System; Esterases; Glutathione Transferase; Heart; Heart Failure; Humans; Isosorbide Dinitrate; Muscle Relaxation; Muscle, Smooth, Vascular; Myocardial Infarction; Nitrates; Nitroglycerin; Oxygen Consumption; Structure-Activity Relationship; Vasodilator Agents | 1994 |
Nitrate therapy and the development of tolerance.
Topics: Angina Pectoris; Drug Tolerance; Humans; Isosorbide Dinitrate; Nitrates; Nitroglycerin; Pentaerythritol Tetranitrate; Vasodilator Agents | 1993 |
NO-donors and angina pectoris: more than just symptomatic treatment?
Topics: Angina Pectoris; Animals; Endothelium, Vascular; Free Radicals; Humans; Isosorbide Dinitrate; Nitric Oxide; Vasodilation; Vasodilator Agents | 1997 |
Achieving sustained improvement in myocardial perfusion: role of isosorbide mononitrate.
Topics: Angina Pectoris; Coronary Circulation; Humans; Isosorbide Dinitrate; Vasodilator Agents | 1997 |
Nitrate therapy for stable angina pectoris.
Topics: Angina Pectoris; Drug Therapy, Combination; Drug Tolerance; Humans; Isosorbide Dinitrate; Nitrates; Nitroglycerin; Vasodilator Agents | 1998 |
Long-acting isosorbide mononitrate.
Topics: Angina Pectoris; Delayed-Action Preparations; Humans; Isosorbide Dinitrate; Vasodilator Agents | 1999 |
Isosorbide 5-mononitrate: a review of a sustained-release formulation (Imdur) in stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Delayed-Action Preparations; Drug Synergism; Humans; Isosorbide Dinitrate; Patient Compliance; Quality of Life | 1999 |
Optimal nitrate therapy with a once-daily sustained-release formulation of isosorbide mononitrate.
Topics: Angina Pectoris; Circadian Rhythm; Clinical Trials as Topic; Delayed-Action Preparations; Drug Tolerance; Humans; Isosorbide Dinitrate; Nitrates; Vasodilator Agents | 1999 |
Isosorbide mononitrate 30% immediate-release 70% sustained-release formulation: a review. DUMQOL (DUtch Mononitrate Quality of Life) Study Group.
Topics: Administration, Oral; Angina Pectoris; Delayed-Action Preparations; Humans; Isosorbide Dinitrate; Quality of Life; Treatment Outcome; Vasodilator Agents | 2000 |
Efficacy of isosorbide mononitrate in angina pectoris.
Topics: Angina Pectoris; Clinical Trials as Topic; Drug Administration Schedule; Drug Tolerance; Humans; Isosorbide Dinitrate; Vasodilator Agents | 1992 |
Nitrate tolerance--can it be prevented?
Topics: Angina Pectoris; Delayed-Action Preparations; Drug Tolerance; Humans; Isosorbide Dinitrate; Nitrates | 1991 |
Clinical experience with Imdur in angina pectoris. A review.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Delayed-Action Preparations; Drug Interactions; Drug Tolerance; Humans; Isosorbide Dinitrate; Nitroglycerin | 1990 |
Development of long-acting nitrate delivery systems.
Topics: Administration, Cutaneous; Administration, Oral; Angina Pectoris; Delayed-Action Preparations; Humans; Isosorbide Dinitrate; Nitrates; Nitroglycerin | 1990 |
Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate.
Topics: Angina Pectoris; Coronary Disease; Delayed-Action Preparations; Drug Administration Schedule; Drug Tolerance; Humans; Isosorbide Dinitrate; Nitrates; Nitroglycerin | 1990 |
Long-term therapeutic efficacy with once-daily isosorbide-5-mononitrate (Imdur).
Topics: Angina Pectoris; Delayed-Action Preparations; Humans; Isosorbide Dinitrate | 1990 |
[Long-term therapy with nitrates. How can continuous effectiveness be achieved?].
Topics: Administration, Cutaneous; Angina Pectoris; Coronary Disease; Delayed-Action Preparations; Drug Administration Schedule; Humans; Isosorbide Dinitrate; Nitrates | 1989 |
Relationship of pharmacokinetic and pharmacodynamic properties of the organic nitrates.
Topics: Angina Pectoris; Animals; Dose-Response Relationship, Drug; Drug Tolerance; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Nitroglycerin | 1988 |
The therapeutic role of isosorbide-5-mononitrate+ in stable and unstable angina pectoris.
Topics: Angina Pectoris; Clinical Trials as Topic; Drug Tolerance; Hemodynamics; Humans; Isosorbide Dinitrate | 1986 |
105 trial(s) available for isosorbide-5-mononitrate and Angor Pectoris
| Article | Year |
|---|---|
Exogenous nitric oxide inhibits Rho-associated kinase activity in patients with angina pectoris: a randomized controlled trial.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Atherosclerosis; Biomarkers; Female; Humans; Isosorbide Dinitrate; Leukocytes; Male; Middle Aged; Nitric Oxide; Nitric Oxide Donors; Prospective Studies; rho-Associated Kinases | 2015 |
[Quality of life and angina pectoris. Comparison of the effects of 2 nitrate derivatives administered discontinuously: transdermal 10 mg nitroglycerine patch (12 hours) and long-acting oral 40 mg isosorbide-5-mononitrate (once a day)].
Topics: Administration, Cutaneous; Administration, Oral; Angina Pectoris; Cross-Over Studies; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Quality of Life; Vasodilator Agents | 2001 |
Safety of nitrate withdrawal in angina-free and hemodynamically stable patients with coronary artery disease.
Topics: Aged; Angina Pectoris; Coronary Disease; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Prospective Studies; Safety; Vasodilator Agents | 2003 |
Preservation of platelet responsiveness to nitroglycerine despite development of vascular nitrate tolerance.
Topics: Aged; Angina Pectoris; Blood Platelets; Cross-Over Studies; Delayed-Action Preparations; Drug Resistance; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitric Oxide; Nitroglycerin; Platelet Aggregation; Vasodilator Agents | 2005 |
[Paired bicycle exercise test in assessment of clinical efficacy of isosorbide-5-mononitrate in patients with stable angina of effort].
Topics: Aged; Angina Pectoris; Exercise Test; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Physical Exertion; Vasodilator Agents | 2005 |
[Efficacy of isosorbide-5-mononitrate retard in patients with stable exertional angina].
Topics: Aged; Angina Pectoris; Delayed-Action Preparations; Electrocardiography; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Physical Exertion; Quality of Life; Surveys and Questionnaires; Vasodilator Agents | 2005 |
[Selection of therapy with nitrates in patients with stable effort angina: results of comparative study of common isosorbide dinitrate and long acting preparation of isosorbide-5-mononitrate].
Topics: Aged; Angina Pectoris; Cross-Over Studies; Delayed-Action Preparations; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Vasodilator Agents | 2005 |
Efficacy and safety of controlled-release isosorbide-5-mononitrate in Japanese patients with stable effort angina pectoris.
Topics: Aged; Angina Pectoris; Delayed-Action Preparations; Double-Blind Method; Drug Tolerance; Exercise Test; Exercise Tolerance; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Reproducibility of Results; Treatment Outcome; Vasodilator Agents | 2006 |
Double-blind, multicenter, active-controlled, randomized clinical trial to assess the safety and efficacy of orally administered nicorandil in patients with stable angina pectoris in China.
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Anti-Arrhythmia Agents; China; Double-Blind Method; Exercise; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nicorandil; Nitroglycerin; Vasodilator Agents | 2007 |
[Evaluation of different methods of treatment of patients with stable stenocardia combined with arterial hypertension according to echocardiographic data].
Topics: Adult; Aged; Angina Pectoris; Chronotherapy; Comorbidity; Drug Therapy, Combination; Echocardiography; Female; Humans; Hypertension; Isosorbide Dinitrate; Male; Melatonin; Middle Aged; Severity of Illness Index; Treatment Outcome; Vasodilator Agents; Ventricular Function, Left | 2007 |
[Coronary therapeutic effectiveness of low-dose IS-5-MN in comparison with the combination IS-5-MH and metipranolol and placebo].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Isosorbide Dinitrate; Male; Metipranolol; Middle Aged; Propanolamines | 1983 |
Is isosorbide mononitrate better than the dinitrate?
Topics: Angina Pectoris; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Humans; Isosorbide Dinitrate | 1984 |
[Treatment of coronary disease with elantan. Results of a multicenter study].
Topics: Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged | 1984 |
[Prevention of the development of tolerance to isosorbide dinitrate in interval therapy].
Topics: Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Electrocardiography; Heart Rate; Humans; Isosorbide Dinitrate | 1984 |
[Long-term tolerance and therapeutic coronary effect of isosorbide-5-mononitrate. Open multicenter study of ISMO 20].
Topics: Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Drug Tolerance; Female; Humans; Isosorbide Dinitrate; Long-Term Care; Male; Middle Aged | 1983 |
Intra-individual comparison of the action of equal doses of isosorbide-5-endomononitrate, slow-release isosorbide dinitrate and placebo in patients with coronary heart disease.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Electrocardiography; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Nitroglycerin | 1983 |
[Randomized double-blind comparative study: glycerol trinitrate and isosorbide mononitrate].
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin | 1983 |
[Nitrate tolerance: pro and con].
Topics: Angina Pectoris; Cardiac Output; Clinical Trials as Topic; Drug Administration Schedule; Drug Tolerance; Headache; Heart Rate; Humans; Hypertension; Isosorbide Dinitrate; Long-Term Care; Nitrates; Nitroglycerin | 1984 |
Treatment of coronary heart disease with isosorbide mononitrate ('Elantan' 20).
Topics: Aged; Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin | 1984 |
[Results of a clinical multicenter study with Mono Mack 20 mg/40 mg].
Topics: Adult; Aged; Angina Pectoris; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged | 1983 |
[Comparison of the anti-angina effect and effect duration of isosorbide dinitrate, isosorbide-2-mononitrate (IS-2-MN) and isosorbide-5-mononitrate (IS-5-MN)].
Topics: Angina Pectoris; Delayed-Action Preparations; Hemodynamics; Humans; Isosorbide Dinitrate; Male | 1981 |
Differences in ischemic threshold and nitrate efficacy between normotensive and hypertensive patients with stable angina pectoris.
Topics: Aged; Angina Pectoris; Antihypertensive Agents; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Humans; Hypertension; Isosorbide Dinitrate; Male; Middle Aged; Vasodilator Agents | 1995 |
Antianginal effect of transdermal nitroglycerin and oral nitrates given for 24 hours a day in 2,456 patients with stable angina pectoris. The Italian Multicenter Study.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Angina Pectoris; Chronic Disease; Circadian Rhythm; Drug Tolerance; Female; Humans; Isosorbide Dinitrate; Italy; Male; Middle Aged; Nitroglycerin; Pentaerythritol Tetranitrate; Vasodilator Agents | 1995 |
Short and long-acting oral nitrates for stable angina pectoris.
Topics: Administration, Oral; Angina Pectoris; Delayed-Action Preparations; Drug Therapy, Combination; Drug Tolerance; Humans; Isosorbide Dinitrate; Nitrates; Nitroglycerin; United States; United States Food and Drug Administration; Vasodilator Agents | 1994 |
Comparison between felodipine and isosorbide mononitrate as adjunct to beta blockade in patients > 65 years of age with angina pectoris.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Felodipine; Female; Humans; Isosorbide Dinitrate; Male; Myocardial Ischemia; Prospective Studies; Treatment Outcome; Vasodilator Agents | 1994 |
[Isosorbide-5-mononitrate in angina pectoris: its efficacy and absence of tolerance and rebound with an eccentric type of administration].
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Angina Pectoris; Canada; Drug Tolerance; Exercise Test; Female; Humans; Isosorbide Dinitrate; Israel; Male; Middle Aged; Survival Analysis; Time Factors; United Kingdom; United States; Vasodilator Agents | 1994 |
Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Electrocardiography; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Physical Exertion; Single-Blind Method; Time Factors; Vasodilator Agents | 1994 |
Once- versus twice-daily administration of controlled-release isosorbide-5-mononitrate 60 mg in the treatment of stable angina pectoris. A randomized, double-blind, cross-over study. The Swedish Multicentre Group.
Topics: Analysis of Variance; Angina Pectoris; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Exercise Test; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Vasodilator Agents | 1994 |
Eccentric dosing with isosorbide-5-mononitrate in angina pectoris.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Electrocardiography; Exercise Test; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Ischemia; Placebos; Tablets; Time Factors; Vasodilator Agents | 1993 |
Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris.
Topics: Adult; Angina Pectoris; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Single-Blind Method; Vasodilator Agents | 1993 |
Effect of isosorbide-5-mononitrate on plasma and urine levels of cyclic GMP in relation to exercise in coronary patients compared with control subjects.
Topics: Angina Pectoris; Coronary Disease; Cyclic GMP; Exercise; Exercise Test; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Vasodilator Agents | 1995 |
A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily, and isosorbide dinitrate twice daily in patients with chronic stable angina.
Topics: Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nifedipine; Treatment Outcome; Vasodilator Agents | 1996 |
Nitrate-induced headache in patients with stable angina pectoris: beneficial effect of starting on a low dosage. 5-ISMN headache study group.
Topics: Adult; Aged; Angina Pectoris; Cross-Over Studies; Double-Blind Method; Female; Headache; Humans; Isosorbide Dinitrate; Male; Middle Aged; Vasodilator Agents | 1996 |
[The therapeutic and prophylactic use of Olicard-Retard under outpatient polyclinical conditions in stenocardia patients].
Topics: Aged; Ambulatory Care; Angina Pectoris; Chronic Disease; Delayed-Action Preparations; Humans; Isosorbide Dinitrate; Middle Aged; Vasodilator Agents | 1997 |
Comparison of multiple-dose and once-daily nitrate therapy in 1212 patients with stable angina pectoris: effects on quality of life indices. Dutch Mononitrate Quality of Life (DUMQOL) Study Group.
Topics: Activities of Daily Living; Administration, Sublingual; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angina Pectoris; Calcium Channel Blockers; Drug Administration Schedule; Exercise Tolerance; Female; Follow-Up Studies; Humans; Isosorbide Dinitrate; Male; Middle Aged; Netherlands; Patient Compliance; Quality of Life; Reproducibility of Results; Stress, Psychological; Tablets; Vasodilator Agents | 1997 |
Effect of extended-release isosorbide mononitrate one hour after dosing in patients with stable angina pectoris. IMDUR Study Group.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Delayed-Action Preparations; Double-Blind Method; Exercise Test; Exercise Tolerance; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Vasodilator Agents | 1997 |
Effects on heart rate variability of isosorbide-5-mononitrate and metoprolol in patients with recent onset of angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angina Pectoris; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Isosorbide Dinitrate; Male; Metoprolol; Middle Aged; Vasodilator Agents | 1998 |
Randomized, double-blind crossover study to investigate the effects of amlodipine and isosorbide mononitrate on the time course and severity of exercise-induced myocardial stunning.
Topics: Aged; Amlodipine; Angina Pectoris; Calcium Channel Blockers; Cross-Over Studies; Double-Blind Method; Echocardiography; Exercise Test; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Stunning; Tomography, Emission-Computed, Single-Photon | 1998 |
Anti-ischemic and anti-anginal effects of controlled-release and conventional isosorbide-5-mononitrate in stable angina pectoris.
Topics: Aged; Angina Pectoris; Cross-Over Studies; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Ischemia; Vasodilator Agents | 1998 |
Comparison of 50-mg and 100-mg sustained-release isosorbide mononitrate in the treatment of stable angina pectoris: effects on quality-of-life indices. Dutch Mononitrate Quality of Life (DUMQOL) Study Group.
Topics: Aged; Angina Pectoris; Delayed-Action Preparations; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Quality of Life; Vasodilator Agents | 1999 |
Safety and efficacy of Hartone in stable angina pectoris--an open comparative trial.
Topics: Angina Pectoris; Case-Control Studies; Female; Humans; Isosorbide Dinitrate; Male; Medicine, Ayurvedic; Middle Aged; Plant Extracts; Vasodilator Agents | 1999 |
Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable angina.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Administration, Oral; Aged; Angina Pectoris; Blood Pressure; Contraindications; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitric Oxide Donors; Nitroglycerin; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones | 2000 |
[Comparative study of isosorbide dinitrates and mononitrates in patients with ischemic heart disease and stable angina pectoris caused by stenosing coronary atherosclerosis].
Topics: Aged; Angina Pectoris; Coronary Artery Disease; Coronary Disease; Cost-Benefit Analysis; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Ischemia; Vasodilator Agents | 2000 |
Independent determinants of the efficacy of nitrate therapy.
Topics: Aged; Analysis of Variance; Angina Pectoris; Delayed-Action Preparations; Drug Administration Schedule; Endothelium, Vascular; Female; Humans; Isosorbide Dinitrate; Linear Models; Male; Nitric Oxide Donors; Quality of Life | 2000 |
Factors influencing efficacy of nitrate therapy for stable angina pectoris: a multiple linear regression analysis.
Topics: Angina Pectoris; Coronary Disease; Delayed-Action Preparations; Diabetes Complications; Drug Administration Schedule; Humans; Hypercholesterolemia; Isosorbide Dinitrate; Linear Models; Nitric Oxide Donors; Quality of Life; Treatment Outcome; Vasodilator Agents | 2000 |
Circadian variation of heart rate variability and the rate of autonomic change in the morning hours in healthy subjects and angina patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angina Pectoris; Aortic Bodies; Autonomic Nervous System; Circadian Rhythm; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Isosorbide Dinitrate; Male; Metoprolol; Middle Aged; Reference Values; Vasodilator Agents | 2001 |
[The effect of long-term administration of isosorbide 5-mononitrate (Mononit), nitric oxide donor, on gallbladder emptying in patients with chronic stable angina].
Topics: Aged; Angina Pectoris; Chronic Disease; Drug Administration Schedule; Female; Gallbladder; Gallbladder Emptying; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitric Oxide Donors; Ultrasonography | 2001 |
A double-blind, parallel-group study of amlodipine versus long-acting nitrate in the management of elderly patients with stable angina.
Topics: Aged; Aged, 80 and over; Amlodipine; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Delayed-Action Preparations; Double-Blind Method; Edema; Exercise Test; Exercise Tolerance; Female; Headache; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Quality of Life; Time Factors; Vasodilator Agents | 2001 |
[Anti-ischemic efficacy of sustained-release isosorbide-5-mononitrate: echocardiography during mental and physical stress].
Topics: Adult; Angina Pectoris; Confidence Intervals; Data Interpretation, Statistical; Delayed-Action Preparations; Double-Blind Method; Echocardiography; Electrocardiography; Exercise Test; Humans; Isosorbide Dinitrate; Male; Middle Aged; Placebos; Stress, Physiological; Stress, Psychological; Time Factors; Vasodilator Agents | 2001 |
Selected issues from an overview on nicorandil: tolerance, duration of action, and long-term efficacy.
Topics: Administration, Oral; Administration, Sublingual; Angina Pectoris; Drug Administration Schedule; Drug Tolerance; Exercise; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Niacinamide; Nicorandil; Nitroglycerin | 1992 |
Combined gallopamil and isosorbide-5-mononitrate in "mixed" angina pectoris.
Topics: Aged; Angina Pectoris; Double-Blind Method; Drug Therapy, Combination; Electrocardiography, Ambulatory; Exercise; Female; Gallopamil; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Ischemia | 1992 |
Influence of isosorbide-5-mononitrate on the circadian rhythm of angina pectoris.
Topics: Aged; Angina Pectoris; Circadian Rhythm; Coronary Disease; Electrocardiography; Female; Humans; Isosorbide Dinitrate; Male | 1992 |
Absence of pre-dose rebound phenomena with once daily 5-ISMN in a controlled-release formulation.
Topics: Adult; Aged; Angina Pectoris; Delayed-Action Preparations; Double-Blind Method; Drug Tolerance; Exercise Test; Humans; Isosorbide Dinitrate; Middle Aged; Sweden; Time Factors; Vasodilator Agents | 1992 |
Effects of 8:00 a.m. and 2:00 p.m. doses of isosorbide-5-mononitrate during twice-daily therapy in stable angina pectoris.
Topics: Aged; Angina Pectoris; Blood Pressure; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Prospective Studies; Vasodilator Agents | 1992 |
Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina.
Topics: Aged; Angina Pectoris; Atenolol; Blood Pressure; Double-Blind Method; Drug Combinations; Exercise Test; Female; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nifedipine; Nitroglycerin; Prospective Studies | 1991 |
Acute and chronic effects of once-daily isosorbide-5-mononitrate on the exercise capacity of patients with angina pectoris treated with a beta-blocking drug.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Physical Endurance | 1991 |
[Randomized, double-blind comparison of isosorbide-5-mononitrate and delayed-action nifedipine in patients with stable exertional angina. Multicenter Study Group].
Topics: Angina Pectoris; Delayed-Action Preparations; Double-Blind Method; Drug Costs; Exercise Test; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nifedipine; Physical Exertion; Quality of Life | 1991 |
Evaluation of the antianginal and anti-ischemic efficacy of slow-release isosorbide-5-mononitrate capsules, bupranolol and their combination, in patients with chronic stable angina pectoris.
Topics: Aged; Angina Pectoris; Bupranolol; Chronic Disease; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged | 1991 |
Isosorbide-5-mononitrate and atenolol in the treatment of stable exertional angina.
Topics: Aged; Angina Pectoris; Atenolol; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Female; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Physical Exertion | 1991 |
Evaluation of the antianginal effect of isosorbide-5-mononitrate in patients with chronic stable angina pectoris.
Topics: Adult; Angina Pectoris; Blood Pressure; Chronic Disease; Double-Blind Method; Exercise Test; Female; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged | 1991 |
Treatment of angina pectoris with isosorbide-5-mononitrate. A multicenter study in general practice.
Topics: Aged; Angina Pectoris; Chronic Disease; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged | 1991 |
Sustained-release IS-5-MN in the treatment of coronary heart disease.
Topics: Angina Pectoris; Chronic Disease; Coronary Disease; Delayed-Action Preparations; Double-Blind Method; Electrocardiography; Exercise Test; Humans; Isosorbide Dinitrate; Male; Monitoring, Physiologic | 1991 |
[A new anti-ischemic drug for the treatment of stable effort angina pectoris: nicorandil. Comparison with placebo and isosorbide-5-mononitrate].
Topics: Aged; Angina Pectoris; Double-Blind Method; Exercise Test; Humans; Isosorbide Dinitrate; Male; Middle Aged; Niacinamide; Nicorandil; Placebos; Vasodilator Agents | 1991 |
Comparison of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in a slow-release form on exercise-induced myocardial ischemia.
Topics: Adult; Aged; Angina Pectoris; Delayed-Action Preparations; Double-Blind Method; Electrocardiography; Exercise Test; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Physical Exertion | 1991 |
[Nitrate tolerance measured by exercise test. Comparison of 2 preparations].
Topics: Aged; Angina Pectoris; Drug Tolerance; Exercise Test; Humans; Isosorbide Dinitrate; Middle Aged; Nitroglycerin | 1991 |
Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
Topics: Angina Pectoris; Delayed-Action Preparations; Double-Blind Method; Electrocardiography; Exercise Test; Humans; Isosorbide Dinitrate | 1991 |
[Changes in exercise capacity and in induced ischemia with an oral dose of 5 isosorbide mononitrate in patients with stable angina pectoris].
Topics: Administration, Oral; Aged; Angina Pectoris; Coronary Disease; Exercise Test; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Physical Endurance; Single-Blind Method | 1990 |
Comparison of the effects of a controlled-release formulation of isosorbide-5-mononitrate and conventional isosorbide dinitrate on exercise performance in men with stable angina pectoris.
Topics: Angina Pectoris; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Exercise; Humans; Isosorbide Dinitrate; Male; Middle Aged; Randomized Controlled Trials as Topic; Time Factors | 1990 |
Efficacy of isosorbide-5-mononitrate on painful and silent myocardial ischemia after myocardial infarction.
Topics: Adult; Aged; Angina Pectoris; Drug Administration Schedule; Electrocardiography, Ambulatory; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Single-Blind Method | 1990 |
[A new antianginal preparation: isosorbide-5-mononitrate].
Topics: Angina Pectoris; Chromatography, Gas; Delayed-Action Preparations; Humans; Isosorbide Dinitrate; Time Factors | 1990 |
N-acetylcysteine modifies the acute effects of isosorbide-5-mononitrate in angina pectoris patients evaluated by exercise testing.
Topics: Acetylcysteine; Administration, Sublingual; Adult; Angina Pectoris; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Exercise Test; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Random Allocation | 1989 |
Efficacy of controlled-release isosorbide-5-mononitrate as adjunctive treatment to beta-blocking agents in patients with stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Female; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Random Allocation | 1989 |
Lack of effect of asymmetrical dosage timing of isosorbide-5-mononitrate on nitrate tolerance during long-term administration.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Patient Compliance; Random Allocation | 1989 |
A randomised double-blind crossover study of isosorbide mononitrate and nifedipine retard in chronic stable angina.
Topics: Aged; Angina Pectoris; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Exercise Test; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Nifedipine; Nitroglycerin; Random Allocation; Vasodilator Agents | 1989 |
Effects of diltiazem and isosorbide-5-mononitrate, alone and in combination, on patients with stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Diltiazem; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Exercise Test; Headache; Heart Rate; Humans; Isosorbide Dinitrate; Middle Aged; Nitroglycerin; Random Allocation; Rest | 1989 |
[Lack of tolerance development in interval therapy with 50 mg isosorbide-5-nitrate retard (Elantan long)].
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Delayed-Action Preparations; Drug Administration Schedule; Exercise Test; Heart Rate; Humans; Isosorbide Dinitrate; Long-Term Care; Male; Middle Aged; Pulmonary Wedge Pressure; Vasodilator Agents | 1989 |
[Efficacy and length of action of a slow-release formulation of isosorbide-5-mononitrate in stable effort angina].
Topics: Adult; Aged; Angina Pectoris; Child; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Isosorbide Dinitrate; Middle Aged; Random Allocation; Time Factors | 1989 |
[Effects of slow-release isosorbide-5-mononitrate on ergometric parameters and cardiac output in stable effort angina pectoris: a double-blind randomized placebo study].
Topics: Adult; Aged; Angina Pectoris; Cardiac Output; Delayed-Action Preparations; Double-Blind Method; Exercise Test; Humans; Isosorbide Dinitrate; Male; Middle Aged; Placebos; Randomized Controlled Trials as Topic | 1989 |
Sustained effect of and lack of development of tolerance to controlled-release isosorbide-5-mononitrate in chronic stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Delayed-Action Preparations; Double-Blind Method; Drug Tolerance; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Random Allocation; Vasodilator Agents | 1989 |
Long term efficacy of a controlled-release formulation of isosorbide 5-mononitrate (Imdur) in angina patients receiving beta-blockers.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Random Allocation | 1987 |
Mononitrates in combination with beta-blocker therapy in the treatment of severe angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitrates; Random Allocation | 1987 |
Anti-anginal efficacy of a controlled-release formulation of isosorbide-5-mononitrate once daily in angina patients on chronic beta-blockade.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Female; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Random Allocation | 1988 |
[Effects of oral administration of subcontinuous doses of delayed-action isosorbide-5-mononitrate. Absence of tolerance].
Topics: Administration, Oral; Aged; Angina Pectoris; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Drug Tolerance; Humans; Isosorbide Dinitrate; Male; Middle Aged; Random Allocation | 1988 |
Comparative clinical trial of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate in ischaemic heart disease.
Topics: Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Delayed-Action Preparations; Double-Blind Method; Electrocardiography; Exercise Test; Female; Headache; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin | 1986 |
Antianginal efficacy and tolerability of 50 mg sustained-release isosorbide 5-mononitrate in an open twelve-month observation study.
Topics: Adult; Aged; Angina Pectoris; Delayed-Action Preparations; Drug Therapy, Combination; Drug Tolerance; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin | 1987 |
An evaluation of the effects of isosorbide 5-mononitrate in patients with angina on effort using dynamic electrocardiography and echocardiography.
Topics: Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Echocardiography; Electrocardiography; Female; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Monitoring, Physiologic; Physical Exertion | 1987 |
Influence of isosorbide 5-mononitrate 20 mg, sustained-release 50 mg and sustained-release nifedipine 20 mg on ischaemic ST-segment changes during Holter monitoring. A double-blind cross-over study in patients with spontaneous angina pectoris.
Topics: Angina Pectoris; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Electrocardiography; Humans; Isosorbide Dinitrate; Monitoring, Physiologic; Nifedipine | 1987 |
Medical treatment of patients with severe exertional and rest angina: double blind comparison of beta blocker, calcium antagonist, and nitrate.
Topics: Aged; Angina Pectoris; Atenolol; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nifedipine; Random Allocation | 1987 |
Isosorbide-5-mononitrate and isosorbide dinitrate retard in the treatment of coronary heart disease: a multi-centre study.
Topics: Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Delayed-Action Preparations; Female; Headache; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Random Allocation | 1987 |
Isosorbide-5-mononitrate and nifedipine can reduce ischaemic ST-segment changes during Holter monitoring in patients with spontaneous angina pectoris.
Topics: Activities of Daily Living; Aged; Angina Pectoris; Delayed-Action Preparations; Double-Blind Method; Electrocardiography; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Monitoring, Physiologic; Nifedipine; Random Allocation | 1988 |
[The effect of time and dosage of isosorbide mononitrate on objective and subjective parameters in angina pectoris].
Topics: Aged; Angina Pectoris; Circadian Rhythm; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Quality of Life | 1988 |
[Delayed-action isosorbide-5-mononitrate preparations--are there differences in the acute effect?].
Topics: Angina Pectoris; Coronary Disease; Delayed-Action Preparations; Dose-Response Relationship, Drug; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged | 1987 |
The effect of isosorbide-5-mononitrate (5-ISMN) Durules on exercise tolerance in patients with exertional angina pectoris. A placebo controlled study.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Delayed-Action Preparations; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Physical Exertion; Placebos; Random Allocation | 1986 |
[Anti-angina action and tolerance of isosorbide-5-mononitrate or nifedipine in retard form].
Topics: Angina Pectoris; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Drug Tolerance; Exercise Test; Humans; Isosorbide Dinitrate; Nifedipine; Random Allocation | 1986 |
The therapeutic role of isosorbide-5-mononitrate+ in stable and unstable angina pectoris.
Topics: Angina Pectoris; Clinical Trials as Topic; Drug Tolerance; Hemodynamics; Humans; Isosorbide Dinitrate | 1986 |
[Intraindividual dose-response relationship of sustained-release Elantan].
Topics: Aged; Angina Pectoris; Clinical Trials as Topic; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Random Allocation | 1986 |
Enhanced platelet sensitivity to prostacyclin after isosorbide-5-mononitrate in patients with stable angina pectoris.
Topics: Adult; Angina Pectoris; Blood Platelets; Epoprostenol; Female; Humans; In Vitro Techniques; Isosorbide Dinitrate; Male; Middle Aged; Platelet Aggregation; Thromboxane B2 | 1986 |
Isosorbide-5-mononitrate in angina pectoris: plasma concentrations and duration of effects after acute therapy.
Topics: Administration, Oral; Aged; Angina Pectoris; Blood Pressure; Double-Blind Method; Drug Evaluation; Electrocardiography; Exercise Test; Humans; Isosorbide Dinitrate; Male; Middle Aged; Random Allocation | 1987 |
Experience of long term treatment and different dosage regimens of isosorbide 5-mononitrate.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Delayed-Action Preparations; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged | 1987 |
Usefulness of twice-daily isosorbide-5-mononitrate in preventing development of tolerance in angina pectoris.
Topics: Aged; Angina Pectoris; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Exercise Test; Humans; Isosorbide Dinitrate; Male; Middle Aged; Physical Exertion; Random Allocation; Time Factors | 1987 |
Acute and sustained effects of isosorbide 5-mononitrate in stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged | 1986 |
Duration of effects and tolerance of slow-release isosorbide-5-mononitrate for angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Delayed-Action Preparations; Double-Blind Method; Drug Tolerance; Electrocardiography; Exercise Test; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Random Allocation | 1987 |
[4 different nitrate preparations with regard to the possible development of tolerance in long-term treatment].
Topics: Administration, Oral; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Circulation; Coronary Disease; Delayed-Action Preparations; Drug Tolerance; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Isosorbide Dinitrate; Long-Term Care; Male; Middle Aged; Myocardial Contraction; Nitroglycerin | 1985 |
Randomized crossover trial of isosorbide mononitrate (Elantan 20) and slow-release glyceryl trinitrate in the treatment of angina pectoris.
Topics: Administration, Oral; Aged; Angina Pectoris; Clinical Trials as Topic; Delayed-Action Preparations; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Physical Exertion; Random Allocation; Time Factors | 1985 |
[Efficacy and duration of action of isosorbide-5-mononitrate in the treatment of stable angina of effort. Comparison with sustained-release isosorbide dinitrate].
Topics: Adult; Angina Pectoris; Delayed-Action Preparations; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Physical Exertion | 1985 |
56 other study(ies) available for isosorbide-5-mononitrate and Angor Pectoris
| Article | Year |
|---|---|
Nitrate allergy and desensitization in a patient with refractory angina.
Topics: Aged; Angina Pectoris; Desensitization, Immunologic; Drug Eruptions; Drug Hypersensitivity; Humans; Injections, Intradermal; Isosorbide Dinitrate; Male; Nitroglycerin; Skin Tests; Vasodilator Agents | 2019 |
A novel multi-unit tablet for treating circadian rhythm diseases.
Topics: Administration, Oral; Angina Pectoris; Cardiovascular Agents; Cellulose; Chemistry, Pharmaceutical; Chronobiology Disorders; Delayed-Action Preparations; Drug Carriers; Excipients; Hypromellose Derivatives; Isosorbide Dinitrate; Kinetics; Methacrylates; Methylcellulose; Microscopy, Electron, Scanning; Polymers; Solubility; Tablets; Technology, Pharmaceutical | 2013 |
[Comparative Assessment of Effects of Isosorbide Dinitrate, Isosorbide-5-Mononitrate and Nicorandil on the Frequency of Angina Attacks and Vasoregulating Endothelial Function in Patients With Ischemic Heart Disease].
Topics: Adult; Aged; Angina Pectoris; Electrocardiography; Female; Humans; Incidence; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Ischemia; Nicorandil; Risk Assessment; Russia; Vasodilation | 2015 |
[Antianginal and anti-ischemic effects of Mono Mac 50D preparation as an agent in combined treatment of patients with stable angina].
Topics: Angina Pectoris; Delayed-Action Preparations; Electrocardiography; Exercise Test; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitric Oxide Donors; Time Factors; Vasodilator Agents | 2002 |
[How is antianginal therapy with pentaerythritol tetranitrate executed?].
Topics: Angina Pectoris; Animals; Delayed-Action Preparations; Drug Administration Schedule; Heart Diseases; Humans; Isosorbide Dinitrate; Pentaerythritol Tetranitrate; Time Factors; Vasodilator Agents | 2002 |
[Results of international study of quality of life of patients with stable angina treated with nitrates (IQOLAN)].
Topics: Angina Pectoris; Exercise Tolerance; Humans; Isosorbide Dinitrate; Nitric Oxide Donors; Patient Satisfaction; Quality of Life; Treatment Outcome | 2003 |
Comparison of once daily versus twice daily oral nitrates in stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Humans; Isosorbide Dinitrate; Middle Aged; Patient Compliance; Randomized Controlled Trials as Topic; Treatment Outcome; Vasodilator Agents | 2004 |
Nitroglycerin: a blast from the past remains a trusted standby. Nitrates offer quick, effective relief from a common heart disease symptom, often for just pennies per dose.
Topics: Angina Pectoris; Drug Interactions; Humans; Isosorbide Dinitrate; Myocardial Infarction; Nitroglycerin; Vasodilator Agents | 2005 |
[Effects of isosorbide-5-mononitrate on clinical condition, bicycle ergometry results, endothelium-dependent vasodilation in patients with ischemic heart disease with stable effort angina].
Topics: Adult; Aged; Angina Pectoris; Blood Flow Velocity; Brachial Artery; Endothelium, Vascular; Exercise Test; Exercise Tolerance; Follow-Up Studies; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Ischemia; Nitroglycerin; Physical Exertion; Time Factors; Treatment Outcome; Ultrasonography; Vasodilation; Vasodilator Agents | 2005 |
[ECG and BP monitoring in patients with stable angina and essential hypertension on therapy with monocinque].
Topics: Adult; Aged; Angina Pectoris; Blood Pressure Monitors; Delayed-Action Preparations; Electrocardiography, Ambulatory; Female; Humans; Hypertension; Isosorbide Dinitrate; Male; Middle Aged; Nitric Oxide Donors; Time Factors; Treatment Outcome; Vasodilator Agents | 2005 |
[Long-term therapy with nitrates. Relation between dosage and tolerance effect].
Topics: Adult; Angina Pectoris; Coronary Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug Tolerance; Hemodynamics; Humans; Isosorbide Dinitrate; Long-Term Care; Middle Aged; Nitroglycerin | 1984 |
Treatment of coronary heart disease with isosorbide mononitrate ('Elantan' 20): a multi-centre study in hospital and general practice.
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitrates; Nitroglycerin | 1984 |
[Tolerance or hemodynamic adaptation during nitrate therapy].
Topics: Adaptation, Physiological; Angina Pectoris; Drug Tolerance; Hemodynamics; Humans; Isosorbide Dinitrate; Nitrates; Vasodilator Agents | 1984 |
[Previous history and principles of the development of isosorbide-5-mononitrate (IS-5-MN)].
Topics: Angina Pectoris; Animals; Biotransformation; Humans; Isosorbide Dinitrate | 1981 |
[Hemodynamic effects of isosorbide-5-mononitrate at rest and during exertion in patients with serious angina pectoris].
Topics: Adult; Aged; Angina Pectoris; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Physical Exertion | 1981 |
The rationale for nitrates in angina pectoris.
Topics: Angina Pectoris; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Humans; Isosorbide Dinitrate; Male; Nitrates; Nitroglycerin; Patient Compliance; Vasodilator Agents | 1995 |
Drugs for stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Humans; Isosorbide Dinitrate; Nitroglycerin; Vasodilator Agents | 1994 |
[The efficacy of 2 new drug forms of isosorbide-5-mononitrate in patients with stable stenocardia of effort].
Topics: Adult; Angina Pectoris; Chronic Disease; Delayed-Action Preparations; Drug Evaluation; Electrocardiography; Exercise Test; Humans; Isosorbide Dinitrate; Middle Aged; Physical Exertion; Time Factors; Vasodilator Agents | 1994 |
The antianginal effect of isosorbide mononitrate.
Topics: Angina Pectoris; Drug Administration Schedule; Drug Tolerance; Humans; Isosorbide Dinitrate; Vasodilator Agents | 1994 |
Eccentric dosing and exercise time.
Topics: Angina Pectoris; Humans; Isosorbide Dinitrate; Vasodilator Agents | 1994 |
Isosorbide-5-mononitrate in angina pectoris.
Topics: Angina Pectoris; Drug Administration Schedule; Humans; Isosorbide Dinitrate; Vasodilator Agents | 1994 |
Extended-release isosorbide mononitrate for angina.
Topics: Angina Pectoris; Clinical Trials as Topic; Delayed-Action Preparations; Drug Tolerance; Humans; Isosorbide Dinitrate | 1994 |
Nitrate tolerance--problems both new and old.
Topics: Administration, Cutaneous; Administration, Oral; Angina Pectoris; Delayed-Action Preparations; Drug Tolerance; Heart Failure; Humans; Injections, Intravenous; Isosorbide Dinitrate; Myocardial Ischemia; Nitroglycerin; Vasodilator Agents | 1996 |
Twenty-four hour plasma profile of sustained-release isosorbide mononitrate in healthy volunteers and in patients with chronic stable angina. Two open label trials.
Topics: Adult; Angina Pectoris; Blood Pressure; Delayed-Action Preparations; Female; Heart Rate; Humans; Isosorbide Dinitrate; Male; Vasodilator Agents | 1997 |
Comments on 'A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily and isosorbide dinitrate twice daily in patients with stable angina'.
Topics: Angina Pectoris; Delayed-Action Preparations; Humans; Isosorbide Dinitrate; Nifedipine; Vasodilator Agents | 1997 |
[The anti-anginal efficacy of the drug forms of isosorbide-5-mononitrate--Monocinque, Monocinque retard and isosorbide dinitrate].
Topics: Angina Pectoris; Drug Evaluation; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Ischemia; Physical Exertion; Vasodilator Agents | 1997 |
Cost analysis of once-daily ISMN versus twice-daily ISMN or transdermal patch for nitrate prophylaxis.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Angina Pectoris; Delayed-Action Preparations; Drug Administration Schedule; Drug Costs; Exercise; Humans; Isosorbide Dinitrate; Middle Aged; Models, Statistical; United Kingdom; Vasodilator Agents | 1997 |
[The effect on painful and silent myocardial ischemia of the preparations Efox and Efox Long in patients with stenocardia of effort].
Topics: Angina Pectoris; Chronic Disease; Delayed-Action Preparations; Drug Evaluation; Electrocardiography, Ambulatory; Exercise Test; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Ischemia; Physical Exertion; Time Factors; Vasodilator Agents | 1997 |
[Time-dependent hemodynamic effects of monosan (Isosorbide-5-mononitrate) in anginal patients].
Topics: Angina Pectoris; Circadian Rhythm; Delayed-Action Preparations; Female; Follow-Up Studies; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Time Factors; Vasodilator Agents | 1998 |
Effectiveness of modified release isosorbide mononitrate affected by incorrect use.
Topics: Aged; Angina Pectoris; Chest Pain; Humans; Isosorbide Dinitrate; Male; Vasodilator Agents | 2000 |
Intermittent nitrate therapy for prior myocardial infaraction does not induce rebound angina nor reduce cardiac events.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Angina Pectoris; Cardiovascular Agents; Coronary Vasospasm; Delayed-Action Preparations; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Exercise Tolerance; Female; Follow-Up Studies; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Recurrence; Retrospective Studies; Treatment Outcome | 2000 |
[Comparative study of retard and non-retard forms of isosorbide-5-mononitrate in coronary patients with stable angina pectoris].
Topics: Administration, Oral; Aged; Angina Pectoris; Delayed-Action Preparations; Electrocardiography; Exercise Tolerance; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Treatment Outcome; Vasodilator Agents | 2000 |
Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs.
Topics: Aged; Angina Pectoris; British Columbia; Cost Control; Cost Savings; Drug Costs; Drug Prescriptions; Economics, Pharmaceutical; Formularies as Topic; Health Policy; Humans; Isosorbide Dinitrate; Nitroglycerin; Prescription Fees; Rate Setting and Review; Vasodilator Agents | 2001 |
[Administration of various dosages of retard isosorbide-5-mononitrate in patients with stable angina pectoris on combined therapy].
Topics: Adult; Aged; Angina Pectoris; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Vasodilator Agents | 2002 |
Isosorbide mononitrate for angina.
Topics: Angina Pectoris; Clinical Trials as Topic; Humans; Isosorbide Dinitrate | 1992 |
Evaluation of effectiveness and tolerability of isosorbide mononitrate during a three-year period in patients with angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Coronary Disease; Exercise Test; Female; Headache; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Risk Factors | 1991 |
Slow release isosorbide-5-mononitrate therapy in angina pectoris. Effects of exercise performance and hemodynamics.
Topics: Aged; Angina Pectoris; Chronic Disease; Coronary Disease; Delayed-Action Preparations; Drug Administration Schedule; Exercise; Hemodynamics; Humans; Isosorbide Dinitrate; Middle Aged | 1991 |
Interval treatment of coronary artery disease with sustained-release isosorbide-5-mononitrate.
Topics: Adult; Angina Pectoris; Coronary Disease; Delayed-Action Preparations; Drug Administration Schedule; Exercise Test; Humans; Isosorbide Dinitrate; Male; Middle Aged; Pulmonary Wedge Pressure | 1990 |
Lack of tolerance after chronic administration of controlled-release isosorbide-5-mononitrate. Interaction of nitrate and gallopamil.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Delayed-Action Preparations; Drug Interactions; Drug Therapy, Combination; Drug Tolerance; Electrocardiography; Female; Gallopamil; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Radionuclide Ventriculography | 1990 |
Anti-ischemic and antianginal effects of 60 mg isosorbide-5-mononitrate in patients treated chronically after myocardial infarction.
Topics: Adult; Aged; Angina Pectoris; Delayed-Action Preparations; Drug Administration Schedule; Drug Tolerance; Exercise; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction | 1990 |
Effectiveness of interval nitrate therapy in angina pectoris.
Topics: Administration, Cutaneous; Angina Pectoris; Drug Administration Schedule; Drug Tolerance; Humans; Isosorbide Dinitrate; Nitrates; Nitroglycerin | 1989 |
Abrupt withdrawal of isosorbide 5-mononitrate (Imdur) after long term treatment in stable angina pectoris. A preliminary report.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Isosorbide Dinitrate; Middle Aged; Substance Withdrawal Syndrome | 1987 |
Slow-release isosorbide-5-mononitrate--a new once daily therapeutic modality for angina pectoris.
Topics: Administration, Oral; Adult; Angina Pectoris; Delayed-Action Preparations; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Physical Exertion | 1988 |
When does nitrate tolerance develop? What dosages and which intervals are necessary to ensure maintained effectiveness?
Topics: Administration, Cutaneous; Administration, Oral; Angina Pectoris; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Electrocardiography; Exercise Test; Humans; Isosorbide Dinitrate; Nitroglycerin; Random Allocation | 1988 |
Abrupt withdrawal of isosorbide-5-mononitrate in Durules (Imdur) after long term treatment in patients with stable angina pectoris.
Topics: Acute Disease; Aged; Angina Pectoris; Delayed-Action Preparations; Drug Tolerance; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Substance Withdrawal Syndrome | 1988 |
Sustained-release isosorbide mononitrate (50 mg): optimization of a once-daily dosage form for long-term treatment of angina pectoris.
Topics: Adolescent; Adult; Angina Pectoris; Biological Availability; Delayed-Action Preparations; Drug Administration Schedule; Humans; Isosorbide Dinitrate; Male; Tablets | 1988 |
[Evaluation of the therapeutic efficacy of slow-release isosorbide-5-mononitrate in ischemic cardiopathy].
Topics: Adult; Aged; Angina Pectoris; Delayed-Action Preparations; Drug Evaluation; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged | 1987 |
[Ergometric evaluation of slow-release isosorbide-5-mononitrate in exertional angina with stable threshold].
Topics: Adult; Aged; Angina Pectoris; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Exercise Test; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged | 1987 |
Mononitrates as monotherapy in the prophylactic treatment of angina pectoris.
Topics: Angina Pectoris; Delayed-Action Preparations; Humans; Isosorbide Dinitrate; Nitrates | 1987 |
The efficacy of isosorbide-5-mononitrate on effort-induced electrocardiographic ischemic changes in patients with angina pectoris.
Topics: Angina Pectoris; Drug Evaluation; Electrocardiography; Exercise Test; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Time Factors | 1987 |
Effects of isosorbide-5-mononitrate on exercise-induced hemodynamic changes in angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Coronary Circulation; Electrocardiography; Exercise Test; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Pulmonary Wedge Pressure; Vascular Resistance | 1986 |
[Influence of isosorbide-5-mononitrate on the tolerance test to exertion in angina pectoris].
Topics: Angina Pectoris; Double-Blind Method; Echocardiography; Exercise Test; Humans; Isosorbide Dinitrate; Male | 1985 |
[Value of nitrates in modern coronary therapy].
Topics: Angina Pectoris; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Hemodynamics; Humans; Isosorbide Dinitrate; Long-Term Care; Nitrates | 1985 |
Isosorbide-5-mononitrate--effective monotherapy in chronic stable angina.
Topics: Administration, Oral; Aged; Angina Pectoris; Chronic Disease; Coronary Disease; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Physical Exertion | 1985 |
[Isosorbide-5-mononitrate. A metabolite of isosorbide dinitrate].
Topics: Angina Pectoris; Humans; Isosorbide Dinitrate | 1985 |
Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris.
Topics: Angina Pectoris; Biological Availability; Coronary Disease; Delayed-Action Preparations; Humans; Isosorbide Dinitrate | 1985 |